IPS strengthens its knowledge in regulatory affairs for Software as a Medical Device (SaMD)
From June 24 to July 30, 2026, the IPS team participated in a specialized training program on Health Regulatory Affairs focused on Software as a Medical Device (SaMD), delivered by the College of Biomedical Engineers (CIB).
IPSLearn: Regulatory knowledge to navigate new challenges in the market
During July, IPSLearn hosted two webinars focused on topics of particular relevance to companies operating in the healthcare sector and international trade. Through these sessions, IPS shared practical knowledge and tools to help professionals stay up to date and make informed decisions in response to regulatory and commercial challenges in the Mexican market.
Classification Consultation Requirements: Key considerations for a stronger regulatory strategy
On July 24, IPS, in collaboration with the National Association of the Dietary Supplement Industry (ANAISA), hosted the webinar “Classification Consultation Requirements,” an educational session aimed at professionals and companies in the dietary supplement industry seeking to strengthen their understanding of regulatory processes before COFEPRIS.